Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumabAtsushi Mitsuhashi, Yasuhiko Nishioka|Nature Communications|2015Cited by 78
Programmed death (PD)‐1/PD‐ligand 1 blockade mediates antiangiogenic effects by tumor‐derived CXCL10/11 as a potential predictive biomarkerAtsushi Mitsuhashi, Yasuhiko Nishioka|Cancer Science|2021Cited by 16
Development, validation, and comparison of gene analysis methods for detecting <i>EGFR</i> mutation from non-small cell lung cancer patients-derived circulating free DNAMasaki Hanibuchi, Yasuhiko Nishioka|Oncotarget|2019Cited by 6